Shun Lu
陆舜
MD, PhD
Director, Department of Medical Oncology肿瘤内科主任
👥Biography 个人简介
Dr. Shun Lu is a leading thoracic oncologist at Shanghai Chest Hospital, renowned for EGFR-targeted therapy research in Chinese NSCLC patients. He has led pivotal trials establishing treatment standards for Chinese lung cancer populations and contributed extensively to Asia-Pacific oncology guidelines.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
EGFR-targeted Therapy
Led landmark clinical trials of EGFR TKIs in Chinese NSCLC patients, generating pivotal efficacy and safety data that informed Asia-Pacific treatment guidelines.
Chinese Patient Data
Established large-scale real-world datasets on lung cancer epidemiology and treatment outcomes specific to Chinese populations, bridging global and regional evidence.
Immunotherapy Research
Conducted key studies on PD-1/PD-L1 inhibitor combinations in Chinese lung cancer patients, advancing first-line immunotherapy options in the region.
Representative Works 代表性著作
Aumolertinib versus gefitinib as first-line treatment for EGFR-mutated advanced NSCLC (AENEAS)
Journal of Clinical Oncology (2022)
Demonstrated superior PFS of third-generation EGFR TKI aumolertinib over gefitinib in Chinese NSCLC patients, establishing a new regional standard of care.
Sintilimab plus chemotherapy vs chemotherapy for first-line NSCLC (ORIENT-11)
Annals of Oncology (2021)
Showed significant PFS improvement with sintilimab-chemotherapy combination, supporting PD-1 inhibitor use in Chinese advanced NSCLC.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
关注 陆舜 的研究动态
Follow Shun Lu's research updates
留下邮箱，当我们发布与 Shun Lu（Shanghai Chest Hospital, Shanghai Jiao Tong University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment